发明授权
- 专利标题： Fused bicyclic kinase inhibitors
- 专利标题（中）： 融合的双环激酶抑制剂
-
申请号： US13108024申请日： 2011-05-16
-
公开(公告)号： US08445510B2公开(公告)日： 2013-05-21
- 发明人: Mark J. Mulvihill , Arno G. Steinig , Andrew Philip Crew , Meizhong Jin , Andrew Kleinberg , An-Hu Li , Jing Wang
- 申请人： Mark J. Mulvihill , Arno G. Steinig , Andrew Philip Crew , Meizhong Jin , Andrew Kleinberg , An-Hu Li , Jing Wang
- 申请人地址： US NY Farmingdale
- 专利权人： OSI Pharmaceuticals, LLC
- 当前专利权人： OSI Pharmaceuticals, LLC
- 当前专利权人地址： US NY Farmingdale
- 代理商 Frank W. Forman
- 主分类号： A61K31/437
- IPC分类号： A61K31/437 ; C07D471/04
摘要：
Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
公开/授权文献
- US20110281888A1 Fused Bicyclic Kinase Inhibitors 公开/授权日：2011-11-17
信息查询
IPC分类:
